/w EPDw ULLTE4N






ShareThis

 Who We Are

 What We Do
 Biophamaceutical Solutions
 Get Involved
 News
 Contact

Contact

  

BIO Ventures for Global Health

401 Terry Avenue North

Seattle, WA 98109
info[at]bvgh.org

Who We Are

  

 
  
©2013 BIO Ventures for Global Health. Web Design by Gravitate.

To help solve the global health crisis, biopharmaceutical innovation is needed. BIO Ventures for Global Health (BVGH)
works to engage companies to drive partnerships and invest in global health initiatives that result in the new drugs, vaccines,
and diagnostics that will save lives in poor countries.
 /w EPDw ULLTE4N






ShareThis

 Who We Are

 What We Do
 Biophamaceutical Solutions
 Get Involved
 News
 Contact

Biopharmaceutical Solutions
 WIPO Re:Search

 Global Health Primer

 Data Center

  

  
Biopharmaceutical Solutions
Diseases of poverty pose an urgent health problem. Biotechnology can
provide a critical piece of the solution.
In Africa, one child dies of malaria every 30 seconds. Tuberculosis claims nearly 2 million lives a year, most of
them in Sub-Saharan Africa and Southeast Asia. Globally, hundreds of millions of lives are threatened by
parasites and other infectious agents.

Today, biopharmaceutical companies invent most of the new medicines for cancer, cardiovascular disease, or
diabetes. But these are diseases for which there is a commercial return for the investment. Can biotech
innovators play the same pivotal role for neglected diseases?

We believe they can.  We have investigated the Neglected Disease Pipeline and created a library of reports that
encompass our extensive research on global health issues, the biopharmaceutical industry, and research and
development (R&D) for new medicines. Through WIPO Re:Search, we help facilitate new partnerships between
scientists that conduct research on neglected tropical diseases, malaria, and tuberculosis, and product
developers that have come together to make their intellectual property and associated expertise available for
the development of new global health solutions. We believe that by applying developed world technologies to
neglected diseases, biotechnology can have a significant impact on the health of people in developing
countries.

  

 
  
©2013 BIO Ventures for Global Health. Web Design by Gravitate.

To help solve the global health crisis, biopharmaceutical innovation is needed. BIO Ventures for Global Health (BVGH)
works to engage companies to drive partnerships and invest in global health initiatives that result in the new drugs, vaccines,
and diagnostics that will save lives in poor countries.

0 {"__scdoff":"1"}

/w EPDw ULLTE4N





 ShareThis

 Who We Are

 What We Do
 Biophamaceutical Solutions
 Get Involved
 News
 Contact

Biopharmaceutical Solutions
 WIPO Re:Search

 Global Health Primer

 Data Center
o BVGH Reports

Stay Informed
Sign up to stay informed about our latest activities, news, and publications. Learn More»

  
  

  
Reports

BIO Ventures for Global Health has created a library of reports that encompass our extensive research on
global health issues, the biopharmaceutical industry, and research and development (R&D) for new medicines.
These publications:

 Describe the challenges faced by patients in the developing world

 Illustrate how biotechnology companies are uniquely suited to address those challenges
 Explore the incentives needed to encourage the biotechnology industry to invest in R&D for new medicines for the
infectious diseases of poverty
 The more we understand about the global health puzzle, the more
focused we can be in solving it.
Reports

 Biotechnology: Bringing Innovation to Neglected Disease R&D

Describes the overall biotechnology business model and identifies some of the challenges facing biotech
engagement in global health product development.
 Developing New Drugs & Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape
Analyzes which product developers are doing what in the creation of new drugs and vaccines that tackle 23
neglected diseases.
 The Global Health Primer
Provides an introduction to neglected tropical diseases and how the technology biotech companies are already
developing can be used to solve unmet medical needs in poor countries.
 The Global Health Primer 2012 Snapshot
 The Vaccine Landscape for Neglected Diseases: A Perspective from the Global Health Primer
Offers an overview of trends in vaccine development for neglected diseases.
 The Diagnostics Innovation Map: Medical Diagnostics for the Unmet Needs of the Developing World
Outlines the groundbreaking technologies that are paving the way for rapid, accurate diagnoses in the developing
world.
 The Case for Investment in Enterotoxigenic Escherichia coli
Vaccines                                                                                                                                                                  
Provides relevant information for product developers interested in the development of ETEC vaccines.
 Closing the Global Health Innovation Gap: A Role for the Biotechnology Industry in Drug Discovery for Neglected
Diseases
Highlights the biotechnology companies that have the scope, scale, and proven track records to develop new
drugs for neglected diseases.
 Tuberculosis Vaccines: The Case for Investment  
Illustrates how a new tuberculosis vaccine could have a potential global market of $1 billion.
 Advance Market Commitments to Stimulate Industry Investment in Global Health Product Development: A Report
on the Biotech Industry’s Perspective
Reveals how Advance Market Commitments (AMCs) can serve as incentives that attract biotechnology
companies to develop new vaccines for neglected diseases.

 
  

 
  
©2013 BIO Ventures for Global Health. Web Design by Gravitate.

To help solve the global health crisis, biopharmaceutical innovation is needed. BIO Ventures for Global Health (BVGH)
works to engage companies to drive partnerships and invest in global health initiatives that result in the new drugs, vaccines,
and diagnostics that will save lives in poor countries.
 0 {"__scdoff":"1"}

TF+Lp82telvxmF8






ShareThis

 Who We Are

 What We Do
 Biophamaceutical Solutions
 Get Involved
 News
 Contact

BIO Ventures for Global Health

Working to engage companies to drive partnerships and invest in global health initiatives to save lives in poor
countries.
  

BVGH News
Check out BVGH's latest publications, 2012-2013 WIPO Re:Search Partnership Stories and the
2013 Partnership Hub Annual Report.

Working at the Crossroads

KOMO News Features WIPO Re:Search
Nonproft brings researchers, pharma together to treat neglected
diseases

SEATTLE – A Seattle-based nonprofit is coordinating partnerships between medical researchers and pharmaceutical companies to address
diseases that are typically neglected by drug developers.

The U.S. Centers for Disease Control estimates 219 million people were infected with malaria in 2010. Another 100 million people are
believed to be infected with dengue fever each year. Despite their prevalence, Jennifer Dent, president of BIO Ventures for Global Health
(BVGH), said in the past major pharmaceutical companies rarely invested in these diseases because there is little money to be made on their
treatments.

Click here for full story.

No news to display.
News at the Crossroads

Catalyzing research for neglected tropical diseases

02/20/2013
In this article, WIPO Magazine hears from WIPO Re:Search partners about why the initiative is creati...
Open innovation
10/04/2012
European Biopharmaceutical Review features the WIPO Re:Search program in its Autumn 2012 issue.
Read...
Drug repurposing
10/02/2012
Chemical & Engineering News reports on the recent trend to find new uses for approved drugs and shel...
  
  
  
©2013 BIO Ventures for Global Health. Web Design by Gravitate.

To help solve the global health crisis, biopharmaceutical innovation is needed. BIO Ventures for Global Health (BVGH)
works to engage companies to drive partnerships and invest in global health initiatives that result in the new drugs, vaccines,
and diagnostics that will save lives in poor countries.

0 {"__scdoff":"1"}